Home
Personalis

Personalis Market Share Analysis for April 2026

Our advanced ctDNA technologies enable the most sensitive detection with cancer insights from molecular residual disease to therapy selection.

Health > Biotechnology and Pharmaceuticals

Domainpersonalis.com

Year Founded2011

Employees201 - 500

Annual Revenue$75M - $100M

Personalis

Personalis (including company regionals)

personalis.com

See more website traffic and engagement information

Personalis Revenue up to April 2026 is 75M - 100M

revenue generated by Personalis top domains

Personalis top domains revenue over 3 years

Revenue for Personalis top domains

personalis.com75M - 100M

See more with Sales Intelligence

Total visits to Personalis's top domains

Understand Personalis market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

personalis.com13.8K

See more with Sales Intelligence

Avg. visit duration in Personalis's top domains

Analyze Personalis engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

personalis.com00:00:40

See more with Sales Intelligence

Avg. pageviews on Personalis's top domains

See how Personalis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

personalis.com1.89

See more with Sales Intelligence

Personalis top competitors by domain

Top similar sites in April 2026, ranked by their affinity

creative-diagnostics.comCompany NameCreative DiagnosticsEmployees51 - 200HQUnited States, New York, ShirleyAnnual revenue$25M - $50MTotal visits132.1KScience and Education > Biology

Top technologies used by Personalis

These are the website technologies, by industry, used by Personalis top domains

Advertising (8)

Google Adsense

Payment & Currencies (8)

Cart Functionality

Widget (6)

Twemoji

Content Management System (3)

WordPress

More Technologies

9

See all

News & Signals from Personalis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPersonalis, Inc. attends event AACR 2026.Personalis highlights clinical impact of ultrasensitive ctDNA monitoring and new Therapy Resistance Tracking at AACR 2026.

NewsPersonalis, Inc. hires Richard Chen as President.Personalis, Inc. appointed Richard Chen as President, adding to his roles as Executive Vice President, R&D, and Chief Medical Officer.

NewsAaron Tachibana leaves Personalis, Inc. as CFO and COO.Personalis, Inc. executive Aaron Tachibana, the company's CFO and COO, reported an acquisition of derivative securities through equity compensation.